目前对大抑郁症治疗psilocybin的理解:一篇专注于临床试验的综述
Sheng-Min Wang1,2, Sunghwan Kim1,2, Won-Seok Choi1,2
1Department of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul, Korea.
概括
西在治疗抑郁症和焦虑症方面表现有前途,作用于大脑受体以减轻症状. 临床试验表明显著改善和持续效果,需要进一步研究最佳剂量.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- псилоцибин是一种幻觉化合物,在心理健康中具有潜在的治疗应用.
- 美国食品和药物管理局在2018年将psilocybin指定为治疗耐药抑郁症 (TRD) 的"突破性疗法".
- 之前的研究表明,psilocybin在控制抑郁和焦虑症状方面具有有效性.
研究的目的:
- 审查已发表的关于西治疗抑郁症的疗效的临床试验.
- 探索潜素抗抑郁和抗焦虑作用背后的神经生物学机制.
- 总结来自开放标签和双盲随机临床试验 (DB-RCTs) 的研究结果.
主要方法:
- 对临床试验的文献综述研究了西对抑郁症的治疗方法.
- 对研究分析了西宾对5-HT2A受体,谷氨酸转移,脑炎症和默认模式网络活动的影响.
- 包括六项开放标签研究和五项DB-RCT的数据.
主要成果:
- 开放标签研究显示,在施用psilocybin后,抑郁症状显著减少,认知偏差有所改善.
- DB-RCTs证明了psilocybin在减少癌症患者的抑郁和焦虑方面的有效性,具有持续的影响.
- 在重大抑郁障碍 (MDD) 和TRD中,psilocybin表现出快速的抗抑郁作用,一些研究表明与埃斯基塔洛普拉姆或安慰剂相比,其结果更好.
结论:
- 西作为治疗抑郁症和焦虑症的显著前景.
- 该化合物在临床环境中表现出良好的安全性.
- 需要进一步的研究来确定最佳的西剂量,并评估长期影响.
相关概念视频
01:18Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:27Depressive Disorders: MDD and Dysthymia
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:27Depressive Disorders: Etiology
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...